Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis
Status:
Completed
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
An evaluation of the safety and efficacy of the calcineurin inhibitor, pimecrolimus cream 1%,
in adult patients with perioral dermatitis.
This study is not enrolling patients in the United States.